Skip to main content
Fig. 1 | World Journal of Surgical Oncology

Fig. 1

From: Selenium nanoparticles (SeNPs) have potent antitumor activity against prostate cancer cells through the upregulation of miR-16

Fig. 1

SeNPs has potent antitumor activities against different cancer cells in vitro. a Inhibition percentages expressed by the SeNPs against eight cancer cell line at a single-dose of 50 μg. b Inhibition percentages expressed by the SeNPs against four prostate cancer cell lines and two normal prostate cells at dose ranges from 25 to 50 μg. c Inhibition percentages expressed by the SeNPs against patients-derived prostate cancer cells at dose ranges from 25 to 100 μg. The %inhibition values were calculated by subtracting the growth percentages from 100.

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us